CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival.
Tubridy EA, Eiva MA, Liu F, Omran DK, Gysler S, Brown EG, Roy AG, Zeng Y, Oh J, Cao Q, Gitto SB, Powell DJ Jr.
Tubridy EA, et al.
Gynecol Oncol. 2024 May;184:74-82. doi: 10.1016/j.ygyno.2024.01.029. Epub 2024 Jan 29.
Gynecol Oncol. 2024.
PMID: 38290413